1 completed, 1 not yet recruiting. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Cerebraca wafer: new trials by email Literature Review of Cerebraca wafer trials Research Report on Cerebraca wafer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma Cerebraca wafer, Temozolomide (for relapsed malignant glioma) - Recurrent Glioblastoma, IDH-Wildtype | Phase 2 / Phase 3 | Not yet recruiting | Everfront Biotech Co., Ltd. | 175 | 2027-04-01 | 2026-09-10 |
| A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma Cerebraca wafer - Recurrent GBM | Phase 1 / Phase 2 | Completed | Everfront Biotech Co., Ltd. | 22 | 2017-11-01 | 2024-09-19 |
Glioblastoma (2) · Astrocytoma (1) · Glioma (1)
Everfront Biotech Co., Ltd. (2)
Taiwan (1) · United States (1)